Alternative approaches to cholesterolin lowering therapy

被引：10

作者：

Grundy, SM

机构：

[1] Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75235 USA

[2] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX USA

[3] Univ Texas, SW Med Ctr, Dept Clin Nutr, Dallas, TX USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2002年 / 90卷 / 10期

关键词：

D O I：

10.1016/S0002-9149(02)02797-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Therapies beyond statins are needed to achieve low-density lipoprotein (LDL) goals in some patients at risk for cardiovascular disease. The cholesterol absorption blocker ezetimibe is a promising addition to the list of LDL lowering drugs.

引用

页码：1135 / +

页数：5

共 28 条

[1]

ARAD Y, 1990, J LIPID RES, V31, P567

[2] Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: Pooled analysis of two phase II studies [J].

Bays, HE ;

Moore, PB ;

Drehobl, MA ;

Rosenblatt, S ;

Toth, PD ;

Dujovne, CA ;

Knopp, RH ;

Lipka, LJ ;

LeBeaut, AP ;

Yang, B ;

Mellars, LE ;

Cuffie-Jackson, C ;

Veltri, EP .

CLINICAL THERAPEUTICS, 2001, 23 (08) :1209-1230

[3] Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy [J].

Blair, SN ;

Capuzzi, DM ;

Gottlieb, SO ;

Nguyen, T ;

Morgan, JM ;

Cater, NB .

AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (01) :46-52

[4] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].

BROWN, MS ;

GOLDSTEIN, JL .

SCIENCE, 1986, 232 (4746) :34-47

[5] Ezetimibe: a selective inhibitor of cholesterol absorption [J].

Catapano, AL .

EUROPEAN HEART JOURNAL SUPPLEMENTS, 2001, 3 (0E) :E6-E10

[6] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[7]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[8] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].

Downs, JR ;

Clearfield, M ;

Weis, S ;

Whitney, E ;

Shapiro, DR ;

Beere, PA ;

Langendorfer, A ;

Stein, EA ;

Kruyer, W ;

Gotto, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622

[9] Efficacy and safety of a potent new selective cholesterol absorption inhibitor, Ezetimibe, in patients with primary hypercholesterolemia [J].

Dujovne, CA ;

Ettinger, MP ;

McNeer, JF ;

Lipka, LJ ;

LeBeaut, AP ;

Suresh, R ;

Yang, B ;

Veltri, EP .

AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (10) :1092-1097

[10] COMBINATION-DRUG THERAPY FOR FAMILIAL COMBINED HYPERLIPIDEMIA [J].

EAST, C ;

BILHEIMER, DW ;

GRUNDY, SM .

ANNALS OF INTERNAL MEDICINE, 1988, 109 (01) :25-32

← 1 2 3 →